Portal de investigación
Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Grau-Pérez M
- Mercader-García P
- Giménez-Arnau AM
- Sanz-Sánchez T
- Ninet VZ
- Guijarro SC
- Miquel FJM
- Salvador JFS
- González-Pérez R
- González IR
- Baldrich ES
- Carrascosa JM
- de Frutos FJO
- Ortega MEG
- Suárez CP
- Triviño FJN
- Chicharro P
- Andreu M
- Gilo AS
- Pereyra Rodríguez JJ
- Nieto MAP
- Melé-Ninot G
- Guillén PS
- de la Fuente EG
- Elosua-González M
- Munera-Campos M
- Romero FT
- Descalzo MÁ
- Borrego L
Grupos
Abstract
BACKGROUND: The REIDAC (Spanish Registry for Research in Contact Dermatitis) conducts nationwide epidemiological surveillance of contact dermatitis in Spain. Anogenital involvement within REIDAC has not been previously studied. OBJECTIVES: To describe the most common diagnoses and update relevant allergens in patients with anogenital lesions referred for patch testing. METHODS: We analysed patients who underwent patch testing within REIDAC from 2019 to 2024. Patients were classified into three groups: (G1) exclusively anogenital lesions, (G2) no anogenital involvement and (G3) both anogenital and non-anogenital lesions. Sensitisation and relevance were assessed. RESULTS: Among 18 291 patients, 116 (0.6%) had exclusively anogenital lesions, 17 576 (96.1%) had no anogenital involvement and 599 (3.3%) had both. G1 patients were more likely to have at least one positive reaction (91.4%), a current relevant reaction (53.4%, diagnosed with allergic contact dermatitis, ACD) and to be polysensitised compared to other groups (p < 0.001). 14.5% of anogenital ACD identified cases were not identified by the Spanish baseline series. Fragrances, preservatives, topical anaesthetics and steroids were the leading relevant allergens. Benzisothiazolinone, sodium metabisulfite and propolis emerged as new sensitisers. CONCLUSION: ACD was highly prevalent among patients with anogenital lesions referred for patch testing. The threshold for patch testing in these patients may need reconsideration.
© 2025 The Author(s). Contact Dermatitis published by John Wiley & Sons Ltd.
Datos de la publicación
- ISSN/ISSNe:
- 0105-1873, 1600-0536
- Tipo:
- Article
- Páginas:
- 272-285
- DOI:
- 10.1111/cod.70048
- PubMed:
- 41365615
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 0,810 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
CONTACT DERMATITIS WILEY
Documentos
- No hay documentos
Filiaciones
Keywords
- allergic contact dermatitis; allergy; anogenital; dermatology; environmental medicine; epidemiology; genital diseases
Cita
Grau M,Mercader P,Giménez AM,Sanz T,Ninet VZ,Guijarro SC,Miquel FJM,Salvador JFS,González R,González IR,Baldrich ES,Carrascosa JM,de Frutos F,SERNA MR,Ortega M,Suárez CP,Triviño FJN,Chicharro P,Andreu M,Gilo AS,Pereyra JJ,Nieto M,Melé G,Guillén PS,de la Fuente EG,Elosua M,Munera M,Romero FT,Descalzo MÁ,Borrego L. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024. Contact Dermatitis. 2026. 94. (3):p. 272-285. IF:4,100. (1).